AU2001266669A1 - Adjuvant preparation for the induction of specific immunity - Google Patents

Adjuvant preparation for the induction of specific immunity

Info

Publication number: AU2001266669A1
Authority: AU; Australia
Prior art keywords: induction; specific immunity; adjuvant preparation; adjuvant; preparation
Prior art date: 2000-05-31
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2001266669A

Other languages

English (en)

Inventor

Zhongyun Dong

Isaiah J Fidler

Weixin Lu

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

University of Texas System

Original Assignee

University of Texas System

University of Texas at Austin

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-05-31

Filing date

2001-05-31

Publication date

2001-12-11

2001-05-31 Application filed by University of Texas System, University of Texas at Austin filed Critical University of Texas System

2001-12-11 Publication of AU2001266669A1 publication Critical patent/AU2001266669A1/en

Status Abandoned legal-status Critical Current

Links

239000002671 adjuvant Substances 0.000 title 1
230000036039 immunity Effects 0.000 title 1
230000006698 induction Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0601—Invertebrate cells or tissues, e.g. insect cells; Culture media therefor
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5152—Tumor cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5156—Animal cells expressing foreign proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A61K2039/55527—Interleukins
- A61K2039/55533—IL-2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
General Health & Medical Sciences (AREA)
Microbiology (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Mycology (AREA)
Biotechnology (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Engineering & Computer Science (AREA)
Cell Biology (AREA)
Biochemistry (AREA)
Oncology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

AU2001266669A 2000-05-31 2001-05-31 Adjuvant preparation for the induction of specific immunity Abandoned AU2001266669A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US20843600P	2000-05-31	2000-05-31
US60208436		2000-05-31
PCT/US2001/017948 WO2001092484A2 (fr)	2000-05-31	2001-05-31	Preparation d'adjuvant pour l'induction d'une immunite specifique

Publications (1)

Publication Number	Publication Date
AU2001266669A1 true AU2001266669A1 (en)	2001-12-11

Family

ID=22774599

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2001266669A Abandoned AU2001266669A1 (en)	2000-05-31	2001-05-31	Adjuvant preparation for the induction of specific immunity

Country Status (6)

Country	Link
US (2)	US6872385B2 (fr)
EP (1)	EP1285059A2 (fr)
JP (1)	JP2003535065A (fr)
AU (1)	AU2001266669A1 (fr)
CA (1)	CA2414207A1 (fr)
WO (1)	WO2001092484A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1562977A4 (fr) *	2002-10-22	2006-12-27	Univ Texas	Immunotherapie active specifique de la metastase cancereuse
WO2008025843A1 (fr) *	2006-09-01	2008-03-06	Inmunología Y Genética Aplicada, S.A.	Adjuvants viraux

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4215051A (en)	1979-08-29	1980-07-29	Standard Oil Company (Indiana)	Formation, purification and recovery of phthalic anhydride
US4745051A (en)	1983-05-27	1988-05-17	The Texas A&M University System	Method for producing a recombinant baculovirus expression vector
US4879236A (en)	1984-05-16	1989-11-07	The Texas A&M University System	Method for producing a recombinant baculovirus expression vector
US5098702A (en)	1986-04-09	1992-03-24	Cetus Corporation	Combination therapy using interleukin-2 and tumor necrosis factor
CA1317244C (fr)	1987-07-24	1993-05-04	Ernest Seigo Kawasaki	Production de formes biologiquement actives de csf a l'aide d'un systeme d'expression baculovirus (acnpv) - cellule d'insecte
US5077214A (en)	1989-07-07	1991-12-31	The Texas A&M University System	Use of baculovirus early promoters for expression of foreign genes in stably transformed insect cells
US5162222A (en)	1989-07-07	1992-11-10	Guarino Linda A	Use of baculovirus early promoters for expression of foreign genes in stably transformed insect cells or recombinant baculoviruses
US5155037A (en)	1989-08-04	1992-10-13	The Texas A&M University System	Insect signal sequences useful to improve the efficiency of processing and secretion of foreign genes in insect systems
US5169784A (en)	1990-09-17	1992-12-08	The Texas A & M University System	Baculovirus dual promoter expression vector
US5681562A (en) *	1991-06-25	1997-10-28	Sidney Kimmel Cancer Center	Lymphokine gene therapy of cancer
ES2144426T3 (es)	1991-10-25	2000-06-16	Sidney Kimmel Cancer Ct	Terapia genica linfoquimica del cancer en combinacion con antigenos tumorales.
CA2114986A1 (fr) *	1993-02-08	1994-08-09	Robert T. Frankot	Selection automatique de zones pour la superposition d'images
CA2179394A1 (fr)	1993-12-23	1995-06-29	Kostas Iatrou	Procedes utilises pour exprimer des proteines dans des cellules d'insectes et procedes utilises pour eliminer des insectes
US5498540A (en)	1994-02-23	1996-03-12	Sea Run Holdings, Inc.	Method for culturing insect cells in a medium containing fish serum
WO1998025574A2 (fr) *	1996-12-10	1998-06-18	Sloan-Kettering Institute For Cancer Research	Procede et compositions destines a stimuler une reponse immune a l'egard d'un antigene de differenciation stimule par un antigene modifie
US6224882B1 (en) *	1997-11-07	2001-05-01	Protein Science Corp.	Insect cells or fractions as adjuvant for antigens
US6103526A (en)	1998-10-08	2000-08-15	Protein Sciences Corporation	Spodoptera frugiperda single cell suspension cell line in serum-free media, methods of producing and using
US6342216B1 (en)	1999-03-17	2002-01-29	The Board Of Regents, The University Of Texas System	Therapy of cancer by insect cells containing recombinant baculovirus encoding genes

2001
- 2001-05-31 WO PCT/US2001/017948 patent/WO2001092484A2/fr not_active Application Discontinuation
- 2001-05-31 CA CA002414207A patent/CA2414207A1/fr not_active Abandoned
- 2001-05-31 AU AU2001266669A patent/AU2001266669A1/en not_active Abandoned
- 2001-05-31 EP EP01944240A patent/EP1285059A2/fr not_active Withdrawn
- 2001-05-31 JP JP2002500676A patent/JP2003535065A/ja not_active Withdrawn
- 2001-05-31 US US09/872,162 patent/US6872385B2/en not_active Expired - Fee Related
2005
- 2005-03-29 US US11/093,269 patent/US20050232906A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP1285059A2 (fr)	2003-02-26
US20050232906A1 (en)	2005-10-20
US20030206890A1 (en)	2003-11-06
CA2414207A1 (fr)	2001-12-06
US6872385B2 (en)	2005-03-29
JP2003535065A (ja)	2003-11-25
WO2001092484A3 (fr)	2002-05-23
WO2001092484A2 (fr)	2001-12-06

Publication	Publication Date	Title
AU2001240115A1 (en)	2001-09-24	Method for the preparation of tetrahydrobenzothiepines
AU2002336760A1 (en)	2003-06-10	Mutable vaccines
AU2001258279A1 (en)	2001-09-24	Adjuvant for vaccines
AU2002241793A1 (en)	2002-06-11	Process for the preparation of organoclays
AU2002254558A1 (en)	2002-11-11	Novel vaccine
AU2464401A (en)	2001-07-16	Process for the preparation of oligomeric compounds
IL187126A0 (en)	2008-02-09	Process for the preparation of 4 - haloalkylnicotinonitriles
AU2001264173A1 (en)	2002-01-08	Process for the isolation of lovastatin
AU2001273762A1 (en)	2002-01-14	Process for the preparation of (r)-2-alkyl-3-phenyl-1-propanols
AU2001272368A1 (en)	2002-01-21	Method for the preparation of citalopram
AUPR030800A0 (en)	2000-10-12	Immunomodulatory preparation
AU2001286775A1 (en)	2002-03-04	Adjuvant
AU8824201A (en)	2002-02-25	Process for the preparation of dinapsoline
AU2001266669A1 (en)	2001-12-11	Adjuvant preparation for the induction of specific immunity
IL150897A0 (en)	2003-02-12	Process for the preparation of acetyl-amidiniophenylalanyl cyclohexylglycyl-pyridinioalaninamides
AU2002329441A1 (en)	2003-05-06	Process for the preparation of 3 - isochromanone
AU2002358085A1 (en)	2003-06-23	Process for the preparation of 4-methyl-7-aminoquinolones
IL190807A0 (en)	2008-11-03	Process for the preparation of 2-aminoethylpyridines
AU5462901A (en)	2001-08-27	Process for the preparation of (pyridinylidene)-phthalides
AU2000279379A1 (en)	2002-05-06	An improved process for the preparation of 10h-phenoxazine
AU2000258438A1 (en)	2001-10-15	An improved process for the preparation of acylferrocenes
AU2002324291A1 (en)	2003-03-10	Process for the preparation of beta-ionylideneacetaldehyde
AU2001292897A1 (en)	2002-04-02	Novel therapy
AU2002216038A1 (en)	2002-05-27	Preparation of monofluoroalkenes
AU2002231651A1 (en)	2002-06-24	Process for the preparation of morpholinones